-
L'Oréal USA to acquire Pacific Bioscience Labs
NEW YORK and REDMOND, Wash. — L’Oréal USA has announced that it plans to acquire Pacific Bioscience Labs, the innovator of sonic skin care technology.
Established in 2001, PBL developed its patented technology, enabling a series of products under the Clarisonic brand that redefined consumers’ approach to skin care. These include the Clarisonic Classic, Clarisonic Mia, Clarisonic PLUS and PRO, and the Clarisonic Opal Sonic Infusion System.
-
Salix to acquire Oceana Therapeutics
RALEIGH, N.C. — Salix Pharmaceuticals has entered a definitive agreement to acquire all outstanding stock of a provider of gastroenterology and urology therapeutics.
Salix said its acquisition of Oceana Therapeutics' outstanding stock is valued at $300 million in cash. The transaction is subject to customary conditions to closing (including U.S. antitrust approval) and is expected to be completed in December.